Results 51 to 60 of about 39,268 (139)

Relative efficacy of minoxidil in combination with other treatments for androgenic alopecia: a network meta-analysis based on randomized controlled trials

Frontiers in Medicine
BackgroundAndrogenetic alopecia is the most prevalent form of progressive hair loss. Minoxidil is widely regarded as a standard treatment for this condition.
Yinfeng Xia, Hong Chen, Yongsong Chen, Zhiyong Chen   +3 more
doaj   +1 more source

The Genetic Landscape of Androgenetic Alopecia: Current Knowledge and Future Perspectives

Biology
Androgenetic alopecia (AGA) is the most common cause of progressive hair thinning in adults and has traditionally been viewed as an androgen-driven inherited condition.
Aditya K. Gupta, Daniel J. Dennis, Vasiliki Economopoulos, Vincent Piguet   +3 more
doaj   +1 more source

Female pattern alopecia: current perspectives

International Journal of Women's Health, 2013
Lauren L Levy, Jason J Emer Department of Dermatology, Mount Sinai School of Medicine, New York, NY, USA Abstract: Hair loss is a commonly encountered problem in clinical practice, with men presenting with a distinctive pattern involving hairline ...
Levy LL, Emer JJ
doaj  

Comparative Analysis of Bacteriome in Hair Follicle Layers of Patients with Female Pattern Androgenic Alopecia

Microorganisms
Androgenetic alopecia (AGA) is the most common form of patterned hair loss, exhibiting gender-specific clinical features. Recent studies highlight the importance of the skin microbiome in maintaining skin health, but the relationship between the hair ...
Yujun Park, Seoyeon Kyung, Seyoung Mun, Byung Sun Yu, Kyengeui Yun, Chaeyun Baek, Dong-Geol Lee, Seunghyun Kang, Soon Re Kim, Ju-Hee Kim, Yeji Lee, Byung-Cheol Park, Kyudong Han   +12 more
doaj   +1 more source

Case series evaluating the efficacy and safety of platelet-rich plasma for androgenetic alopecia in pediatric patients

JAAD Case Reports, 2023
Catherine Tawfik, BS, Christina I. Tejeda, MD, Adrienne M. Haughton, MD   +2 more
doaj   +1 more source

The boosting effect of minoxidil 0.1% when combined with dutasteride 0.01% and microneedling in the treatment of female pattern hair loss

Journal of the Egyptian Women’s Dermatologic Society
Background Female pattern hair loss (FPHL) is a disease characterized by progressive hair thinning. Topical minoxidil is an FDA-approved drug for the treatment of androgenetic alopecia. Dutasteride (a 5α-reductase inhibitor) can also be used in a topical
Reham Essam, Heba Selim, Rana Ehab
doaj   +1 more source

Spironolactone for treatment of female pattern hair loss [PDF]

Journal of the American Academy of Dermatology, 2020
Laura J, Burns, Brianna, De Souza, Elizabeth, Flynn, Dina, Hagigeorges, Maryanne M, Senna   +4 more
openaire   +2 more sources

Differential Diagnosis of Female-Pattern Hair Loss [PDF]

Skin Appendage Disorders, 2016
Daniel, Asz-Sigall, Ana Cecilia, González-de-Cossio-Hernández, Erika, Rodríguez-Lobato, María Fernanda, Ortega-Springall, Maria Elisa, Vega-Memije, Roberto, Arenas Guzmán   +5 more
openaire   +2 more sources

Differences in Demographic and Clinical Characteristics Among Subtypes of Female Pattern Hair Loss. [PDF]

Clin Cosmet Investig Dermatol, 2023
Sakpuwadol N, Tejapira K, Kositkuljorn C, Pomsoong C, Suchonwanit P.   +4 more
europepmc   +1 more source

Association between Family History and Male Androgenetic Alopecia with Female Pattern Hair Loss. [PDF]

Ann Dermatol, 2023
Lee SH, Kang H, Lee WS.
europepmc   +1 more source